Literature DB >> 9799379

Fulminanting necrotising enterocolitis: outcome and prognostic factors.

M Voss1, S W Moore, I van der Merwe, C Pieper.   

Abstract

In order to determine the outcome of infants with fulminant necrotising entercolitis (NEC), the records of 128 surgically-treated neonates were reviewed. Fifty-two were found to have severe, rapid-onset disease. The 30-day survival was determined and correlated with birth weight, gestational age, laboratory and radiological findings, and extent of disease. Seven patients did not respond to resuscitative measures and were treated by percutaneous drainage with a uniformly fatal outcome. For patients who could be made fit for surgery, the only absolute predictor of survival was extent of disease. Pan-necrosis occurred in 19 patients and all of these died. Conversely, patients who had resectable disease had a 30-day survival of 61%. Pan-necrosis could not be determined preoperatively by radiological findings. Patients with severe, rapid-onset NEC and evidence of gangrene who respond to resuscitation should have active surgical management, as approximately one-half of them have resectable disease and a reasonable short-term outcome may be expected. Patients who do not respond to resuscitative measures and those with a surgical finding of pan-necrosis had a uniformly fatal outcome in this study, and if resources are limited, it is reasonable to withdraw active management in this group of patients.

Entities:  

Mesh:

Year:  1998        PMID: 9799379     DOI: 10.1007/s003830050407

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  2 in total

1.  A comparison of neonatal surgical admissions between two linked surgical departments in Africa and Europe.

Authors:  B Nandi; C Mungongo; K Lakhoo
Journal:  Pediatr Surg Int       Date:  2008-06-14       Impact factor: 1.827

2.  Clinical characteristics of neonatal fulminant necrotizing enterocolitis in a tertiary Children's hospital in the last 10 years.

Authors:  Lu Lin; Xuhua Xia; Wei Liu; Yongming Wang; Ziyu Hua
Journal:  PLoS One       Date:  2019-11-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.